Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × LY3023414 × Clear all

NCT02981342 2019-11-20

A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma

Phase 2 Completed

106 enrolled 24 charts

Gastrointestinal

Pancreatic Neoplasms